SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹539 Cr | ₹646 Cr | ₹559 Cr | ₹537 Cr | ₹513 Cr |
What is the latest Total Current Liabilities ratio of SEQUENT SCIENTIFIC ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹539 Cr |
Mar2024 | ₹646 Cr |
Mar2023 | ₹559 Cr |
Mar2022 | ₹537 Cr |
Mar2021 | ₹513 Cr |
How is Total Current Liabilities of SEQUENT SCIENTIFIC Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹539 Cr | -16.58 | |
Mar2024 | ₹646 Cr | 15.53 | |
Mar2023 | ₹559 Cr | 3.98 | |
Mar2022 | ₹537 Cr | 4.72 | |
Mar2021 | ₹513 Cr | - |
Compare Total Current Liabilities of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹4,416.5 Cr | 1.3% | -5.9% | 22.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,192.0 Cr | 0.3% | -4% | -6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,479.0 Cr | 2% | -9.6% | 33.1% | Stock Analytics | |
CIPLA | ₹125,113.0 Cr | 1.9% | 4.5% | -0.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,539.0 Cr | 0.6% | 3.6% | 9.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,926.0 Cr | 2% | -1% | -7% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | 1.3% |
-5.9% |
22.7% |
SENSEX | 1.3% |
-0.8% |
3.2% |
You may also like the below Video Courses